Research
Hormonal
Discontinuation of GLP-1 agonist pharmacotherapy (e.g., semaglutide) leads to rapid weight regain, necessitating indefinite long-term treatment for maintenance.
If you use GLP-1 medications like semaglutide for weight loss, understand that stopping them will likely cause you to regain the weight quickly. These drugs treat obesity as a chronic condition, meaning you likely need to stay on them long-term to keep the weight off, regardless of cost or insurance hurdles.
GoodSupportsHIGH confidence
medication therapy needs to be continued indefinitely as demonstrated in the STEP4 trial which showed rapid weight regain when semaglutide was discontinued.
Why this rating
Based on cited RCT (STEP4) and clinical consensus, though the paper itself is a survey.
Source
Patient Perception of Endoscopic and Medical Therapies for Weight Loss
Monica Saumoy et al. · medRxiv · 2023
DOI 10.1101/2023.09.26.23296199
preprint · n=184
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Endoscopic Bariatric Therapies (EBTs) such as ESG and intragastric balloons are largely unknown to patients, with 78.2% unaware of their existence as weight loss options.Moderate
- Spanish-speaking patients face significantly greater barriers to accessing weight loss information, with higher rates of unawareness regarding both EBTs and pharmacotherapy compared to English-speaking patients.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →